KDA Group not to proceed with the project to distribute the ZRx Prescriber in the United States
Thetford Mines, August 28, 2018 – KDA Group Inc. (TSXV: KDA) (“KDA Group” or the “Corporation”) announced on June 1st, 2018 an agreement with ZoomMed Inc. (TSXV: ZMD) (“ZoomMed”) whereby KDA Group could have obtained the rights to distribute, under a non-exclusive license, the ZRx Prescriber developed by ZoomMed in the United States.
AlliancePharma inc. is recognized for its exceptional performance on the Toronto stock market in 2015
In an article by Gilbert Leduc published in the daily Le Soleil, AlliancePharma inc. was identified as the publicly traded company from the Capitale-Nationale and Chaudière-Appalaches regions that provided the best return on the Toronto stock market in 2015.
